Delhi HC reserves order on Novo’s plea against Dr Reddy’s semaglutide exports
A single-judge bench of Delhi high court had allowed Dr Reddy’s to continue manufacturing and exporting semaglutide to non-patent jurisdictions, while restraining domestic sales until the patent expires in March 2026.
A single-judge bench of Delhi high court had allowed Dr Reddy’s to continue manufacturing and exporting semaglutide to non-patent jurisdictions, while restraining domestic sales until the patent expires in March 2026.
What's Your Reaction?
Economist Admin
Admin managing news updates, RSS feed curation, and PR content publishing. Focused on timely, accurate, and impactful information delivery.
